Gut microbiome shifts from sugary drinks tied to higher diabetes risk

Researchers examine the association between sugar-sweetened beverage intake and gut microbiota-mediated changes that may mitigate the risk of diabetes.

CureVac Advances Seasonal Flu Study to Phase 2 in Collaboration with GSK Following Selection of Promising mRNA Vaccine Candidate with Broad Coverage – Biotech Investments

Issuer: CureVac / Key word(s): Study/Study results 12.09.2023 / 13:00 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac Advances Seasonal

September 13, 2023

Can routinely collected primary care data drive life sciences investment in the UK? – Pharmaceutical Technology

By effectively harnessing this globally unparalleled and extensive health dataset, we have an opportunity to attract and engage global life sciences companies who are looking

June 28, 2024

Cancer Patient’s Final Act: Destroying Medical Debt

A 38-year-old woman who died from ovarian cancer earlier this month posthumously launched a viral campaign that will help pay off an estimated $60 million

November 23, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.